Manufacturers Life Insurance Company, The 2seventy Bio, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 18,771 shares of TSVT stock, worth $56,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,771
Previous 19,656
4.5%
Holding current value
$56,125
Previous $75,000
17.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TSVT
# of Institutions
126Shares Held
45.6MCall Options Held
122KPut Options Held
19.8K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$17.8 Million2.31% of portfolio
-
Goldman Sachs Group Inc New York, NY4.22MShares$12.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.77MShares$11.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$10.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.89MShares$8.65 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $113M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...